Artykuły w czasopismach na temat „Renal Prognosi”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Renal Prognosi”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Silva, G. E. B., R. S. Costa, R. C. Ravinal, M. A. dos Reis, M. Dantas та T. M. Coimbra. "Mast Cells, TGF-β1 andα-SMA Expression in IgA Nephropathy". Disease Markers 24, № 3 (2008): 181–90. http://dx.doi.org/10.1155/2008/725408.
Pełny tekst źródłaYe, Dayong, Jingxian Luo, Yujie Wang, Mingqiang Su, Dayong Zhang, and Dengjun Han. "Prognostic Value and Clinical Significance of Vesicular Transport-Related Genes in Clear Cell Renal Cell Carcinoma." Kidney and Blood Pressure Research 49, no. 1 (2024): 410–29. http://dx.doi.org/10.1159/000539095.
Pełny tekst źródłaPierscianek, Daniela, Marvin Darkwah Oppong, Yahya Ahmadipour, et al. "Electrolyte and renal disorders in patients with newly diagnosed glioblastoma." Future Oncology 17, no. 34 (2021): 4711–19. http://dx.doi.org/10.2217/fon-2020-1312.
Pełny tekst źródłaKalowes, Peggy. "Improving End-of-Life Care Prognostic Discussions." AACN Advanced Critical Care 26, no. 2 (2015): 151–66. http://dx.doi.org/10.4037/nci.0000000000000086.
Pełny tekst źródłaPeng, Xiqi, Xiang Pan, Kaihao Liu, et al. "miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery." International Journal of Biological Markers 34, no. 3 (2019): 302–8. http://dx.doi.org/10.1177/1724600819866456.
Pełny tekst źródłaT J, Dr Cicily. "Aetiology and Prognosis in Pregnancy Related Acute Renal Failure." Journal of Medical Science And clinical Research 05, no. 03 (2016): 19299–305. http://dx.doi.org/10.18535/jmscr/v5i3.155.
Pełny tekst źródłaLi, Xinxin, Qihui Kuang, Min Peng, Kang Yang, and Pengcheng Luo. "Basement Membrane-Associated lncRNA Risk Model Predicts Prognosis and Guides Clinical Treatment in Clear Cell Renal Cell Carcinoma." Biomedicines 11, no. 10 (2023): 2635. http://dx.doi.org/10.3390/biomedicines11102635.
Pełny tekst źródłaJiang, Aimin, Yewei Bao, Anbang Wang, et al. "Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis." Oxidative Medicine and Cellular Longevity 2022 (January 4, 2022): 1–30. http://dx.doi.org/10.1155/2022/3617775.
Pełny tekst źródłaSchiavone, D., A. Isgrò, F. Migliorini, et al. "Prognostic value of clinical parameters for renal cell carcinoma." Urologia Journal 64, no. 2 (1997): 156–64. http://dx.doi.org/10.1177/039156039706400202.
Pełny tekst źródłaHatakeyama, Shingo, Hiromi Murasawa, Itsuto Hamano, et al. "Prognosis of Elderly Japanese Patients Aged ≥80 Years Undergoing Hemodialysis." Scientific World Journal 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/693514.
Pełny tekst źródłaWu, Guangzhen, Jianyi Li, Yingkun Xu, Xiangyu Che, Feng Chen, and Qifei Wang. "A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma." Journal of Oncology 2021 (September 23, 2021): 1–10. http://dx.doi.org/10.1155/2021/2606213.
Pełny tekst źródłaUZUN, Mehmet, Eda ÇALIŞKAN YILDIRIM, Hüseyin Salih SEMİZ, et al. "Examination of Factors Affecting General Survival in Patients with Metastatic Renal Cell Cancer: A Case of Dokuz Eylül University Medical Oncology Clinic." Medical Journal of Western Black Sea 6, no. 2 (2022): 165–71. http://dx.doi.org/10.29058/mjwbs.1084889.
Pełny tekst źródłaKwon, Se Yun, Jun Nyung Lee, Bum Soo Kim, et al. "Impact of Microvascular Invasion and Tumor Necrosis on the Prognosis of Korean Patients with pT1b Renal Cell Carcinoma." Urologia Internationalis 95, no. 1 (2014): 65–71. http://dx.doi.org/10.1159/000366138.
Pełny tekst źródłaLiu, Feng, Chenyu Wang, Rongzhen Wang, Wenge Wang, and Min Li. "Henoch-schonlein purpura nephritis with renal interstitial lesions." Open Medicine 13, no. 1 (2018): 597–604. http://dx.doi.org/10.1515/med-2018-0088.
Pełny tekst źródłaAbdel-Qadir, Husam M., Shaan Chugh, and Douglas S. Lee. "Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome." International Journal of Nephrology 2011 (2011): 1–11. http://dx.doi.org/10.4061/2011/351672.
Pełny tekst źródłaSilva, Rafaela V. N., Lucas A. Berzotti, Marcella G. Laia, et al. "Implications of MTHFD2 expression in renal cell carcinoma aggressiveness." PLOS ONE 19, no. 2 (2024): e0299353. http://dx.doi.org/10.1371/journal.pone.0299353.
Pełny tekst źródłaSemenov, Dmitry. "The Influence of Prognostic Predictors on Survival Rates in Patients with Synchronous Metastases of Renal Cell Cancer in the Lungs." Oncology.kz 1, no. 11 (2024): 4–11. https://doi.org/10.56598/2957-6377-2024-1-11-4-11.
Pełny tekst źródłaZhai, Yaling, Xingchen Yao, Yuanyuan Qi, et al. "Elevated Serum Chloride Levels Contribute to a Poor Prognosis in Patients with IgA Nephropathy." Journal of Immunology Research 2021 (October 8, 2021): 1–9. http://dx.doi.org/10.1155/2021/3598135.
Pełny tekst źródłaKusdjianto, Amanda Yuanita. "The Role of Critical Laboratory Parameters to Determine the Severity and Prognosis of COVID-19: Systematic Review." Cermin Dunia Kedokteran 49, no. 10 (2022): 585–88. http://dx.doi.org/10.55175/cdk.v49i10.311.
Pełny tekst źródłaMuriel, C., E. Esteban, A. Astudillo, et al. "Prognostic factors in patients with advanced renal carcinoma." Journal of Clinical Oncology 29, no. 7_suppl (2011): 391. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.391.
Pełny tekst źródłaTOGUCHI, MASAFUMI, KOUSEI ISHIGAMI, MASATO GOYA, SEIICHI SAITO, SADAYUKI MURAYAMA, and AKIHIRO NISHIE. "Efficacy of Pre-operative 18F-FDG PET/CT in Prognostic Prediction in Patients With Renal Cell Carcinoma." Cancer Diagnosis & Prognosis 2, no. 2 (2022): 216–22. http://dx.doi.org/10.21873/cdp.10097.
Pełny tekst źródłaPourmohammadi, Nadia, Azadeh Khayyat, Mohammad Ali Esmaeil Pour, Maryam Ghasemi, and Parisa Kaviani. "Elderly versus young IgA nephropathy; an update on current data." Journal of Nephropathology 13, no. 4 (2024): e25552. http://dx.doi.org/10.34172/jnp.2024.25552.
Pełny tekst źródłaGanesan, Sarumathy, Prathiba Arumugam, Nithya Ilanchezhian, and Saraswathi Manickam. "Evaluation of Ki67 Expression in Relation to Tumor Stage and Fuhrman Nuclear Grade of Renal Cell Carcinoma and MUC1 Expression in Clear Cell Renal Cell Carcinoma." Journal of Evolution of Medical and Dental Sciences 10, no. 33 (2021): 2718–22. http://dx.doi.org/10.14260/jemds/2021/555.
Pełny tekst źródłaPermi, Harish S. "RENAL CELL CARCINOMA WITH OSSEOUS METAPLASIA OCCURRING IN A CONTRACTED KIDNEY - A RARE CASE REPORT." Journal of Health and Allied Sciences NU 03, no. 04 (2013): 137–38. http://dx.doi.org/10.1055/s-0040-1703721.
Pełny tekst źródłaHanamura, Kikuno, Akihiro Tojo, Satoshi Kinugasa, Kensuke Asaba, and Toshiro Fujita. "The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients." International Journal of Nephrology 2012 (2012): 1–9. http://dx.doi.org/10.1155/2012/139565.
Pełny tekst źródłaFan, Zhiyi, Zhangheng Huang, and Xiaohui Huang. "Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms." Journal of Oncology 2021 (May 12, 2021): 1–17. http://dx.doi.org/10.1155/2021/5575295.
Pełny tekst źródłaLi, Fan, Weifeng Hu, Wei Zhang, Guohao Li, and Yonglian Guo. "A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma." Disease Markers 2020 (February 27, 2020): 1–9. http://dx.doi.org/10.1155/2020/8352809.
Pełny tekst źródłaKanomata, Naoki, Yasufumi Sato, Yoshiyuki Miyaji, Atsushi Nagai, and Takuya Moriya. "Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma." Journal of Clinical Pathology 66, no. 7 (2013): 613–19. http://dx.doi.org/10.1136/jclinpath-2013-201444.
Pełny tekst źródłaZoshima, T., S. Hara, and M. Kawano. "FRI0188 THE CLINICOPATHOLOGICAL SIGNIFICANCE OF MODIFIED NATIONAL INSTITUTES OF HEALTH ACTIVITY AND CHRONICITY SCORING SYSTEM IN LUPUS NEPHRITIS; A MULTICENTER RETROSPECTIVE STUDY." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 677.2–678. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3016.
Pełny tekst źródłaWu, JianPing, QianXia Wu, MinYi Wu, and WeiLin Mao. "Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis." BioMed Research International 2019 (March 4, 2019): 1–6. http://dx.doi.org/10.1155/2019/7272045.
Pełny tekst źródłaSuto, Hironobu, Takuro Fuke, Hiroyuki Matsukawa, et al. "Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study." Journal of Clinical Medicine 13, no. 5 (2024): 1216. http://dx.doi.org/10.3390/jcm13051216.
Pełny tekst źródłaNam, J., C. Park, and T. Kim. "UP-03.152 Prognosis and Prognostic Factors in Renal Pelvis and Ureter Tumors." Urology 78, no. 3 (2011): S394. http://dx.doi.org/10.1016/j.urology.2011.07.1241.
Pełny tekst źródłaGao, Yiren, and Zhen Jia. "Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma." Genetics Research 2022 (November 17, 2022): 1–11. http://dx.doi.org/10.1155/2022/6004852.
Pełny tekst źródłaKovaleva, O. V., A. N. Gratchev, E. I. Makarova, et al. "Prognostic significance of sPD-1/sPD-L1 in renal cancer depending on the phenotype of tumor and stromal cells." Cancer Urology 18, no. 2 (2022): 17–28. http://dx.doi.org/10.17650/1726-9776-2022-18-2-17-28.
Pełny tekst źródłaHorinouchi, Tomoko, Tomohiko Yamamura, China Nagano, et al. "Heterozygous Urinary Abnormality–Causing Variants of COL4A3 and COL4A4 Affect Severity of Autosomal Recessive Alport Syndrome." Kidney360 1, no. 9 (2020): 936–42. http://dx.doi.org/10.34067/kid.0000372019.
Pełny tekst źródłaHong, Green, Da Hyun Kang, Sunghoon Park, et al. "Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation." Journal of Personalized Medicine 14, no. 6 (2024): 657. http://dx.doi.org/10.3390/jpm14060657.
Pełny tekst źródłaCAI, XIAOYAN, XIUYAN YANG, FAN LIAN, et al. "Correlation Between Serum Anti-C1q Antibody Levels and Renal Pathological Characteristics and Prognostic Significance of Anti-C1q Antibody in Lupus Nephritis." Journal of Rheumatology 37, no. 4 (2010): 759–65. http://dx.doi.org/10.3899/jrheum.090779.
Pełny tekst źródłaSciascia, Savino, Martina Cozzi, Alice Barinotti, et al. "Renal Fibrosis in Lupus Nephritis." International Journal of Molecular Sciences 23, no. 22 (2022): 14317. http://dx.doi.org/10.3390/ijms232214317.
Pełny tekst źródłaBansal, Mansi, Ashok Kumar, Anup Mohta, Lalit Aggarwal, and Shadan Ali. "Abdominal wall metastasis and hyponatremia in metastatic renal cell carcinoma." International Surgery Journal 9, no. 5 (2022): 1105. http://dx.doi.org/10.18203/2349-2902.isj20221166.
Pełny tekst źródłaBansal, Mansi, Ashok Kumar, Anup Mohta, Lalit Aggarwal, and Shadan Ali. "Abdominal wall metastasis and hyponatremia in metastatic renal cell carcinoma." International Surgery Journal 9, no. 5 (2022): 1105. http://dx.doi.org/10.18203/2349-2902.isj20221166.
Pełny tekst źródłaAarstad, Helene Hersvik, Gigja Guðbrandsdottir, Karin M. Hjelle, et al. "The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile." Cancers 12, no. 7 (2020): 1961. http://dx.doi.org/10.3390/cancers12071961.
Pełny tekst źródłaMakulo, JR, FB Lepira, EK Sumaili, et al. "Obesity and Renal Prognosis (Assessed by Albuminuria and eGFR) in Type 2 Diabetics in Kinshasa." January 30, 2016. https://doi.org/10.19070/2328-353X-1600030.
Pełny tekst źródła"Obstetric Renal Failure: Causes, Prognosis, Evolution." International Journal of Women's Health care and Gynecology 4, no. 1 (2022): 1–6. http://dx.doi.org/10.36266/ijwhg/138.
Pełny tekst źródłaSilveira, Camila Cristina Sauder da, Matias Nunes Frizzo, and Vitor Antunes de Oliveira. "Marcadores renais como prognóstico para Covid-19." Revista Brasileira de Análises Clínicas 54, no. 4 (2022). http://dx.doi.org/10.21877/2448-3877.202200041.
Pełny tekst źródłaChen, Linbao, Chao Wang, Yuning Wang, Tianyu Hong, Guangwen Zhang, and Xingang Cui. "Functions, Roles, and Biological Processes of Ferroptosis-Related Genes in Renal Cancer: A Pan-Renal Cancer Analysis." Frontiers in Oncology 11 (March 11, 2022). http://dx.doi.org/10.3389/fonc.2021.697697.
Pełny tekst źródłaLiu, Puyu, Jihang Luo, Na Tan, Chengfang Li, Jieyu Xu, and Xiaorong Yang. "Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients." BMC Bioinformatics 24, no. 1 (2023). http://dx.doi.org/10.1186/s12859-023-05229-9.
Pełny tekst źródłaChen, Jiasheng, Nailong Cao, Shouchun Li, and Ying Wang. "Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis." Frontiers in Oncology 11 (March 11, 2021). http://dx.doi.org/10.3389/fonc.2021.630842.
Pełny tekst źródłaYu, Zuhu, Chong Lu, Bin Lu, Hong Gao, Rongfang Liang, and Wuxing Xiang. "A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs." BMC Genomics 24, no. 1 (2023). http://dx.doi.org/10.1186/s12864-023-09258-9.
Pełny tekst źródłaChen, Ji, Yating Zhan, Rongrong Zhang, et al. "A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma." Frontiers in Oncology 11 (June 25, 2021). http://dx.doi.org/10.3389/fonc.2021.700084.
Pełny tekst źródłaIkram, Agrebi, Kammoun Khawla, Dammak Najla, et al. "P0497MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS IN A LMIC : EPIDEMIOLOGIC PROFILE, PROGNOSTIC FACTORS AND IMPACT OF ALPHA SMOOTH MUSCLE ACTIN." Nephrology Dialysis Transplantation 35, Supplement_3 (2020). http://dx.doi.org/10.1093/ndt/gfaa142.p0497.
Pełny tekst źródła